By Elizabeth Cohen, CNN Medical Correspondent
ATLANTA, Georgia (CNN) — Like many young men, Josh Nahum loved a thrill. That’s why he took up skydiving. But on Labor Day weekend in 2006, he had an accident while skydiving in Colorado, fracturing his femur and skull.
Josh spent six weeks in the intensive care unit. Slowly, his condition improved, and his doctors predicted that with rehabilitation, he could fully recover in a year or two.
But instead of recovering, Josh developed a bacterial infection. ...continue reading...
April 15, 2008 – Since Jan. 1, 2007, the deaths of at least eighty-one people have been linked to contaminated heparin. FDA Commissioner Andrew von Eschenbach testified before a Senate Appropriations Committee that the FDA suspected the contamination had been done deliberately, “by virtue of economic fraud.” Read Morecontinue reading...
By Evan George
Daily Journal Staff Writer
This article appears on Page 1
HEMET – Ramon Rodriguez was always good with his hands. The ex-Marine fixed cars, stitched leather and tinkered with home improvements, despite his diabetes and a failed kidney.
But that was before his skin began turning to stone.
It started as a stiffness in his legs and pain in his joints. Then, he began tripping. When his skin toughened, his doctors were puzzled.
Last year, Rodriguez, 65, was ...
The antibiotic Ketek, manufactured by Sanofi-Aventis, had been reported to cause liver failure, blurred vision and loss of consciousness in adults. Twelve adults in the United States suffered liver failure, and four of them died. Twenty-three others suffered serious liver injuries.1
The company undertook a study of Ketek in 24,000 patients to prove its safety. The trial was marred by fraud, one of the investigators on the study is now in federal prison, and another lost his medical license.1
Sanofi-Aventis first ...continue reading...
But assembling a jury for product liability trial in Katrina-ravaged city may prove difficult.
By Aaron Smith, CNNMoney.com staff writer
February 2, 2006: 1:42 PM EST
NEW YORK (CNNMoney.com) – The next big battle over Vioxx takes place in New Orleans, a city mired in its own conflicts with nature, the government and itself.
The retrial of Merck v. Plunkett is scheduled to begin Monday in New Orleans — less than two months after a trial, presided over by U.S. District Judge Eldon Fallon ...continue reading...